This company has been marked as potentially delisted and may not be actively trading.

Arcellx (ACLX) Stock Forecast & Price Target

Get the Latest News and Ratings for ACLX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Arcellx and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACLX Analyst Ratings Over Time

Type	Current Forecast 5/20/25 to 5/20/26	1 Month Ago 4/20/25 to 4/20/26	3 Months Ago 2/19/25 to 2/19/26	1 Year Ago 5/20/24 to 5/20/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	9 Buy rating(s)	13 Buy rating(s)
Hold	16 Hold rating(s)	16 Hold rating(s)	3 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$111.87	$111.87	$109.20	$111.33
Forecasted Upside	-2.78% Downside	-2.72% Downside	64.14% Upside	83.90% Upside
Consensus Rating	Hold	Hold	Moderate Buy	Buy

ACLX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ACLX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Arcellx Stock vs. The Competition

Type	Arcellx	Medical Companies	Broader Market
Consensus Rating Score	2.11	2.29	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	-2.78% Downside	1,728.69% Upside	16.49% Upside
News Sentiment Rating	Positive News See Recent ACLX News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
4/29/2026	Cantor Fitzgerald 5 of 5 stars	Eric Schmidt 5 of 5 stars	Reiterated Rating	Neutral
4/27/2026	Truist Financial 3 of 5 stars		Upgrade	Strong-Buy
4/20/2026	Weiss Ratings Not Rated		Reiterated Rating	Sell (D-)
3/2/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
2/25/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelsey Goodwin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$120.00 ➝ $115.00	+1.09%
2/24/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$100.00 ➝ $115.00	+1.10%
2/24/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Geoff Meacham Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$110.00 ➝ $115.00	+1.10%
2/24/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Market Perform Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform	$115.00	+1.10%
2/23/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Willey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$127.00 ➝ $115.00	+1.10%
2/23/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cory Kasimov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$115.00	+1.04%
Get the Latest News and Ratings for ACLX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arcellx and its competitors with MarketBeat's FREE daily newsletter.
2/23/2026	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$115.00	+1.02%
2/23/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
2/23/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Newman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$115.00	+1.04%
2/23/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Allen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform ➝ Neutral	$106.00 ➝ $115.00	+0.79%
2/23/2026	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Blum Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
2/23/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yanan Zhu Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$115.00	+79.38%
2/12/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Qize Ding Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$82.00	+17.34%
11/18/2025	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kalpit Patel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Peer Perform
7/31/2025	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Farmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Sector Outperform	$93.00 ➝ $133.00	+86.68%
11/29/2024	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Lawson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
11/8/2024	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Biren Amin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$91.00 ➝ $115.00	+15.97%
11/6/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$84.00 ➝ $100.00	+14.78%
11/6/2024	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Overweight	$81.00 ➝ $106.00	+21.67%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:53 PM ET.

ACLX Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Arcellx is $111.87, with a high forecast of $133.00 and a low forecast of $82.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcellx in the last year. There is currently 1 sell rating, 16 hold ratings, 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ACLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACLX, but not buy additional shares or sell existing shares.

According to analysts, Arcellx's stock has a predicted downside of -2.78% based on their 12-month stock forecasts.

Over the previous 90 days, Arcellx's stock had 14 downgrades and 2 upgrades by analysts.

Arcellx has been rated by research analysts at Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, Evercore, Guggenheim, HC Wainwright, Leerink Partners, Needham & Company LLC, Robert W. Baird, Stifel Nicolaus, TD Cowen, Truist Financial, UBS Group, Weiss Ratings, Wells Fargo & Company, and William Blair in the past 90 days.

Analysts like Arcellx less than other "medical" companies. The consensus rating score for Arcellx is 2.11 while the average consensus rating score for "medical" companies is 2.29. Learn more on how ACLX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Arcellx Recommendations

This page (NASDAQ:ACLX) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.